Asahi Life Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Asahi Life Asset Management's BIIB Position: Q2 2025 in Review
Asahi Life Asset Management sold out of Biogen (BIIB) in Q2 2025, closing a stake of 2,345 shares — an estimated $321K sold.
Asahi Life Asset Management first reported a position in BIIB in Q2 2019 and held it in 14 quarters. The position peaked at $546K in Q4 2019. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.
- Asahi Life Asset Management reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
- Asahi Life Asset Management sold 2,345 Biogen shares in Q2 2025, an estimated $321K.
- Asahi Life Asset Management first reported a position in Biogen in Q2 2019 and held it in 14 quarters.
- Asahi Life Asset Management's Biogen position peaked at $546K in Q4 2019.
- 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.
Based on Asahi Life Asset Management's 13F filing for Q2 2025, filed 6 Aug 2025.